GP-Leds

Next Gen alumni on the future of GP-led secondaries

From CVs on CVs to greater specialisation, secondaries professionals who have previously featured on our rising stars list share their insights on the market’s evolution.

Lindsay Goldberg plots build-out of CV investment strategy

The firm is joining a growing number of PE entrants expanding into the secondaries market, Secondaries Investor understands.

How CV dealmakers are addressing LPs’ process pain points

GP-led deal volume hit an all-time high in 2025, but record growth doesn’t necessarily equate to LP satisfaction with continuation vehicle processes.

Exit visibility key in evaluating deals: A&M Capital’s Weisberg

A&M Capital’s secondaries strategy has a focus on mid-market and smaller deals, which is believes offers a more attractive risk-return profile than the larger end, managing partner Jeremy Weisberg said at NEXUS 2026.

Three key trends in GP-led secondaries

The GP-led market is going from strength to strength, but there are still challenges to address.

DPI is IRR – structure in LP sales helps bridge slow exits: StepStone’s Matt Roche

‘It’s been a tough four years for private equity… and it’s why DPI is IRR today – not the new IRR – it is IRR today,’ Matthew Roche, partner with StepStone Group said.

Are CVs the answer to GP stakes exit challenges?

GP-led secondaries would appear to provide an obvious route to liquidity for staking investors but there are some issues to iron out.

Definition of secondaries will evolve as market dynamics shift: Dawson’s Robard

LPs are taking an increasingly proactive approach to the secondaries market, while CVs will represent 10-20% of PE exits, managing partner Yann Robard said at NEXUS 2026.

Are GP-led secondaries deals and evergreen funds a good match?

With evergreen fund investment in GP-led deals on the rise, how compatible are these transactions with vehicles that offer investors a degree of periodic liquidity and, in most cases, diversified exposures?

100% carry rollover table stakes for trophy CVs – NEXUS

Not every company marketed as a trophy asset is indeed a crown jewel, leading to specialised work on behalf of buyers to sort through opportunities, attendees heard at PEI’s NEXUS conference last week.